Your browser doesn't support javascript.
loading
The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.
Lakis, Sotiris; Kotoula, Vassiliki; Eleftheraki, Anastasia G; Batistatou, Anna; Bobos, Mattheos; Koletsa, Triantafyllia; Timotheadou, Eleni; Chrisafi, Sofia; Pentheroudakis, George; Koutras, Angelos; Zagouri, Flora; Linardou, Helena; Fountzilas, George.
Afiliação
  • Lakis S; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. Electronic address: slakis@math.auth.gr.
  • Kotoula V; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Department of Pathology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
  • Eleftheraki AG; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
  • Batistatou A; Department of Pathology, Ioannina University Hospital, Ioannina, Greece.
  • Bobos M; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
  • Koletsa T; Department of Pathology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
  • Timotheadou E; Department of Medical Oncology, "Papageorgiou" Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
  • Chrisafi S; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
  • Pentheroudakis G; Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece.
  • Koutras A; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece.
  • Zagouri F; Department of Clinical Therapeutics, "Alexandra" Hospital, University of Athens School of Medicine, Athens, Greece.
  • Linardou H; First Department of Medical Oncology, "Metropolitan" Hospital, Piraeus, Greece.
  • Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Department of Medical Oncology, "Papageorgiou" Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
Breast ; 23(3): 234-43, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24703723
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores Androgênicos / Taxoides / Antagonistas de Receptores de Andrógenos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Breast Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores Androgênicos / Taxoides / Antagonistas de Receptores de Andrógenos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Breast Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de publicação: Holanda